Evaluation of Chronic Pancreatitis Prognosis Score in an American Cohort
- PMID: 39137098
- PMCID: PMC11596705
- DOI: 10.14309/ctg.0000000000000758
Evaluation of Chronic Pancreatitis Prognosis Score in an American Cohort
Abstract
Introduction: Chronic Pancreatitis Prognosis Score (COPPS) was developed to discriminate disease severity and predict risk for future hospitalizations. In this cohort study, we evaluated if COPPS predicts the likelihood of hospitalization(s) in an American cohort.
Methods: The Chronic Pancreatitis, Diabetes, and Pancreatic Cancer consortium provided data and serum from subjects with chronic pancreatitis (N = 279). COPPS was calculated with baseline data and stratified by severity (low, moderate, and high). Primary endpoints included number and duration of hospitalizations during 12-month follow-up.
Results: The mean ± SD COPPS was 8.4 ± 1.6. COPPS correlated with all primary outcomes: hospitalizations for any reason (number: r = 0.15, P = 0.01; duration: r = 0.16, P = 0.01) and pancreas-related hospitalizations (number: r = 0.15, P = 0.02; duration: r = 0.13, P = 0.04). The severity distribution was 13.3% low, 66.0% moderate, and 20.8% high. 37.6% of subjects had ≥1 hospitalization(s) for any reason; 32.2% had ≥1 pancreas-related hospitalizations. All primary outcomes were significantly different between severity groups: hospitalizations for any reason (number, P = 0.004; duration, P = 0.007) and pancreas-related hospitalizations (number, P = 0.02; duration, P = 0.04). The prevalence of continued drinking at follow-up ( P = 0.04) was higher in the low and moderate groups. The prevalence of anxiety at enrollment ( P = 0.02) and follow-up ( P < 0.05) was higher in the moderate and high groups.
Discussion: Statistically, COPPS significantly correlated with hospitalization outcomes, but the correlations were weaker than in previous studies, which may be related to the outpatient nature of the PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies cohort and lower prevalence of high severity disease. Studies in other prospective cohorts are needed to understand the full utility of COPPS as a potential tool for clinical risk assessment and intervention.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
Conflict of interest statement
Figures
References
-
- Spanier BW, Dijkgraaf MG, Bruno MJ. Trends and forecasts of hospital admissions for acute and chronic pancreatitis in The Netherlands. Eur J Gastroenterol Hepatol 2008;20(7):653–8. - PubMed
-
- Ni Chonchubhair HM, Bashir Y, McNaughton D, et al. Hospital discharges and patient activity associated with chronic pancreatitis in Ireland 2009-2013. Pancreatology 2017;17(1):56–62. - PubMed
MeSH terms
Grants and funding
- U01DK108327/DK/NIDDK NIH HHS/United States
- U01 DK108288/DK/NIDDK NIH HHS/United States
- U01DK108323/DK/NIDDK NIH HHS/United States
- R21DK122293/DK/NIDDK NIH HHS/United States
- U01DK108314/DK/NIDDK NIH HHS/United States
- R21 DK122293/DK/NIDDK NIH HHS/United States
- U01DK108288/DK/NIDDK NIH HHS/United States
- U01 DK108332/DK/NIDDK NIH HHS/United States
- K01 DK120737/DK/NIDDK NIH HHS/United States
- U01DK108300/DK/NIDDK NIH HHS/United States
- U01DK108328/DK/NIDDK NIH HHS/United States
- U01 DK108328/DK/NIDDK NIH HHS/United States
- K01DK120737/DK/NIDDK NIH HHS/United States
- U01DK108326/DK/NIDDK NIH HHS/United States
- U01DK108320/DK/NIDDK NIH HHS/United States
- U01 DK108323/DK/NIDDK NIH HHS/United States
- U01 DK108326/DK/NIDDK NIH HHS/United States
- U01DK108332/DK/NIDDK NIH HHS/United States
- U01 DK108300/DK/NIDDK NIH HHS/United States
- U01 DK108306/DK/NIDDK NIH HHS/United States
- U01 DK108314/DK/NIDDK NIH HHS/United States
- U01 DK108327/DK/NIDDK NIH HHS/United States
- U01DK108306/DK/NIDDK NIH HHS/United States
- U01 DK108320/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
